Elife Holdings Limited: Financial Ratios (10 years), Financial Data

Delayed Deutsche Boerse AG Other stock markets 02:20:02 2023-01-25 am EST			5-day change	1st Jan Change
0.0152 ^EUR	-.--%		-.--%	-.--%

Jun. 28	Elife Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
Feb. 09	Elife Raises HK$19.4 Million From Rights Issue	MT

Summary

Quotes

News

Company

Financials

Valuation

Calendar

Sector

e8b5ea4cc62d1362cd313bd9c.2O0M9Ri9fPDZy7lahb-vmhN4Jy2MJLBnQKw38FyCgoI.jIFjxS7pNrO4h9gw2tTqwHg2d0rTZ-ohDppPhg311OeQvV2UcPIKluC68A

Published financial data: ELIFE HOLDINGS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	-26.99	-16.48	-26.71	-17.24	-0.28
Return on Total Capital	-43.51	-20.83	-34.94	-24.42	-0.84
Return On Equity %	-99.23	-46.52	-82.04	-73.15	-74.39
Return on Common Equity	-49.89	-20.36	-30.01	-20.02	-26.96
Margin Analysis
Gross Profit Margin %	-17.65	3.35	5.14	0.78	17.31
SG&A Margin	12.88	0.36	0.93	1.03	2.66
EBITDA Margin %	-130.87	-11.03	-30.51	-9.91	0.03
EBITA Margin %	-142.74	-12.34	-31.49	-10.37	-0.4
EBIT Margin %	-142.74	-12.34	-31.49	-10.37	-0.4
Income From Continuing Operations Margin %	-175.12	-11.1	-30.51	-10.57	-15.73
Net Income Margin %	-140.42	-9.56	-26.76	-9.07	-17.39
Net Avail. For Common Margin %	-140.42	-9.56	-24.92	-9.07	-16.33
Normalized Net Income Margin	-51.11	-5.38	-13.08	-5.21	-8.61
Levered Free Cash Flow Margin	83.74	-3.22	-0.36	-2.58	13.35
Unlevered Free Cash Flow Margin	84.39	-2.82	0.66	-1.99	13.48
Asset Turnover
Asset Turnover	0.3	2.14	1.36	2.66	1.1
Fixed Assets Turnover	2.4	16.85	13.2	39.04	36.51
Receivables Turnover (Average Receivables)	2.41	17.41	8.33	17.38	2.11
Inventory Turnover (Average Inventory)	10.3	330.4	509.69	147.51	67.72
Short Term Liquidity
Current Ratio	1.63	3.08	1.65	1.89	1.24
Quick Ratio	0.51	1.07	0.67	0.46	1.1
Operating Cash Flow to Current Liabilities	-0.32	-0.31	-0.26	-0.42	-0.14
Days Sales Outstanding (Average Receivables)	151.83	20.97	43.82	21	173.72
Days Outstanding Inventory (Average Inventory)	35.52	1.1	0.72	2.47	5.4
Average Days Payable Outstanding	28.61	0.8	0.47	1.97	159.15
Cash Conversion Cycle (Average Days)	158.74	21.28	44.06	21.5	19.98
Long Term Solvency
Total Debt/Equity	5.24	40.8	68.73	108.98	8.7
Total Debt / Total Capital	4.98	28.98	40.73	52.15	8
LT Debt/Equity	2.09	26.04	3.82	53.16	3.86
Long-Term Debt / Total Capital	1.99	18.49	2.27	25.44	3.55
Total Liabilities / Total Assets	54.28	43.24	57.19	67.23	79.57
EBIT / Interest Expense	-137.21	-19.72	-19.31	-10.95	-2.01
EBITDA / Interest Expense	-120.22	-16.48	-17.94	-9.69	3.74
(EBITDA - Capex) / Interest Expense	-120.33	-16.54	-17.94	-9.71	3.74
Total Debt / EBITDA	-0.05	-1.01	-0.67	-1.27	3.28
Net Debt / EBITDA	0.21	-0.46	-0.41	-1.13	-17.13
Total Debt / (EBITDA - Capex)	-0.05	-1	-0.67	-1.27	3.28
Net Debt / (EBITDA - Capex)	0.21	-0.46	-0.41	-1.12	-17.15
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-38.7	403.82	-44.72	56.51	-22.92
Gross Profit, 1 Yr. Growth %	-267.05	-195.61	-15.1	-76.21	1.61K
EBITDA, 1 Yr. Growth %	-49.86	-52.7	59.84	-49.15	-100.25
EBITA, 1 Yr. Growth %	-47.89	-51.93	46.75	-48.48	-96.95
EBIT, 1 Yr. Growth %	-47.89	-51.93	46.75	-48.48	-96.95
Earnings From Cont. Operations, 1 Yr. Growth %	-40.47	-68.06	56.75	-45.8	26.54
Net Income, 1 Yr. Growth %	-44.5	-65.68	54.68	-46.93	47.69
Normalized Net Income, 1 Yr. Growth %	-60.13	-47.01	40.04	-37.64	44.34
Diluted EPS Before Extra, 1 Yr. Growth %	-59.54	-65.95	39.6	-49.82	19.54
Accounts Receivable, 1 Yr. Growth %	-51.46	13.52	17.26	-61.04	2.07K
Inventory, 1 Yr. Growth %	-85.77	-96.41	814.29	427.54	-33.54
Net Property, Plant and Equip., 1 Yr. Growth %	-37.05	-14.23	-47.11	-47.01	37.94
Total Assets, 1 Yr. Growth %	-40.75	-8.34	-17.97	-22.89	227.14
Tangible Book Value, 1 Yr. Growth %	-25.78	9.84	-13.34	-15.99	25.57
Common Equity, 1 Yr. Growth %	-33.14	9.84	-13.34	-15.99	25.57
Cash From Operations, 1 Yr. Growth %	-57.75	-52.7	35.64	11.3	76.27
Capital Expenditures, 1 Yr. Growth %	-92.88	68.25	-	-	-95.24
Levered Free Cash Flow, 1 Yr. Growth %	758.9	-170.35	-93.12	1.01K	-624.01
Unlevered Free Cash Flow, 1 Yr. Growth %	721.64	-160.1	-114.36	-574.13	-652.03
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-40.17	75.74	66.89	-6.98	9.83
Gross Profit, 2 Yr. CAGR %	1.9	26.38	-9.9	-55.06	101.47
EBITDA, 2 Yr. CAGR %	-24.06	-34.06	-14.95	-9.85	-96.44
EBITA, 2 Yr. CAGR %	-22.26	-33.51	-17.65	-13.05	-87.56
EBIT, 2 Yr. CAGR %	-22.26	-33.51	-17.65	-13.05	-87.56
Earnings From Cont. Operations, 2 Yr. CAGR %	-18.52	-56.4	-30.34	-7.83	-21.14
Net Income, 2 Yr. CAGR %	-22.06	-56.36	-27.14	-9.4	-11.47
Normalized Net Income, 2 Yr. CAGR %	-34.91	-54.02	-15.58	-6.55	-10.91
Diluted EPS Before Extra, 2 Yr. CAGR %	-27.3	-62.88	-33.03	-16.3	-26.88
Accounts Receivable, 2 Yr. CAGR %	-25.84	-25.76	15.38	-32.41	190.64
Inventory, 2 Yr. CAGR %	-56.92	-92.85	-42.69	594.49	87.24
Net Property, Plant and Equip., 2 Yr. CAGR %	-36.08	-26.52	-32.65	-47.06	-14.51
Total Assets, 2 Yr. CAGR %	-33.54	-26.3	-13.29	-20.47	58.83
Tangible Book Value, 2 Yr. CAGR %	-31.5	-9.71	-2.44	-14.68	2.71
Common Equity, 2 Yr. CAGR %	-34.32	-14.3	-2.44	-14.68	2.71
Cash From Operations, 2 Yr. CAGR %	-51.44	-55.3	-19.9	22.87	40.07
Capital Expenditures, 2 Yr. CAGR %	-94.41	-65.39	-	-37.05	-
Levered Free Cash Flow, 2 Yr. CAGR %	-28.67	-57.01	-79.05	-12.52	566.15
Unlevered Free Cash Flow, 2 Yr. CAGR %	-28.37	-59.83	-72.22	-17.48	397.74
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	41.23	21.73	19.52	63.36	-12.63
Gross Profit, 3 Yr. CAGR %	264.29	-0.24	10.69	-42.2	51.05
EBITDA, 3 Yr. CAGR %	-9.22	-37.44	-12.72	-28.35	-87.35
EBITA, 3 Yr. CAGR %	-7.46	-35.91	-14.57	-29.57	-71.68
EBIT, 3 Yr. CAGR %	-7.46	-35.91	-14.57	-29.57	-71.68
Earnings From Cont. Operations, 3 Yr. CAGR %	-14.73	-40.37	-33.89	-35.93	-0.85
Net Income, 3 Yr. CAGR %	-20.33	-40.71	-33.46	-34.45	6.63
Normalized Net Income, 3 Yr. CAGR %	-24.79	-39.22	-34.24	-23.68	3.59
Diluted EPS Before Extra, 3 Yr. CAGR %	-27.95	-43.54	-43.39	-39.18	-9.29
Accounts Receivable, 3 Yr. CAGR %	323.19	-14.53	-13.54	-19.65	114.76
Inventory, 3 Yr. CAGR %	-	-81.18	-63.98	20.1	217.66
Net Property, Plant and Equip., 3 Yr. CAGR %	-15.01	-29.5	-34.15	-37.82	-27.15
Total Assets, 3 Yr. CAGR %	-27.29	-26.03	-23.62	-16.61	27.43
Tangible Book Value, 3 Yr. CAGR %	-29.2	-19.82	-10.94	-7.18	-2.95
Common Equity, 3 Yr. CAGR %	-29.29	-22.04	-13.98	-7.18	-2.95
Cash From Operations, 3 Yr. CAGR %	-26.32	-51.87	-35.28	-10.62	38.57
Capital Expenditures, 3 Yr. CAGR %	-79.03	-82.6	-	-12.64	-73.38
Levered Free Cash Flow, 3 Yr. CAGR %	-1.1	-53.83	-77.41	-21.25	45.06
Unlevered Free Cash Flow, 3 Yr. CAGR %	-0	-55.77	-72.53	-28.47	52.67
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-22.29	7.29	50.98	9.31	15.55
Gross Profit, 5 Yr. CAGR %	10.9	-7.67	108.33	-27.48	40.65
EBITDA, 5 Yr. CAGR %	20.91	-5.58	-13.45	-28.23	-75.73
EBITA, 5 Yr. CAGR %	22.76	-4.23	-13.4	-28.16	-60.47
EBIT, 5 Yr. CAGR %	22.76	-4.23	-13.4	-28.16	-60.47
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.89	-35.13	-21.36	-29.46	-29.06
Net Income, 5 Yr. CAGR %	-8.52	-37.07	-23.13	-29.75	-25.41
Normalized Net Income, 5 Yr. CAGR %	9.35	-16.05	-21.23	-28.39	-25.75
Diluted EPS Before Extra, 5 Yr. CAGR %	-16.82	-41.56	-30.03	-34.68	-37.28
Accounts Receivable, 5 Yr. CAGR %	132	33.8	151.64	-22.19	40.42
Inventory, 5 Yr. CAGR %	-	-	-	-20.3	-30.35
Net Property, Plant and Equip., 5 Yr. CAGR %	-8.82	-10.44	-22.56	-37.13	-26.9
Total Assets, 5 Yr. CAGR %	-19.58	-15.07	-21.98	-23.85	2.36
Tangible Book Value, 5 Yr. CAGR %	4.72	-7.84	-19.51	-17.8	-5.71
Common Equity, 5 Yr. CAGR %	19.12	-11.56	-19.57	-19.17	-7.66
Cash From Operations, 5 Yr. CAGR %	-10.49	1.02	-23.82	-29.98	-11.87
Capital Expenditures, 5 Yr. CAGR %	-50.02	-39.65	-	-70.9	-70.43
Levered Free Cash Flow, 5 Yr. CAGR %	9.83	-49.58	-58.93	-41.53	-12.54
Unlevered Free Cash Flow, 5 Yr. CAGR %	15.13	-50.72	-53.53	-44.49	-12.48

Stock Market
Equities
223 Stock
K4I1 Stock
Financials Elife Holdings Limited
Financial Ratios

Our Free Content Help you Secure and Increase the Performance of Your Investments Secure my Investments

"); for (var element in ICConf) { if (document.getElementById("zpp"+element)) { document.getElementById("zpp"+element).innerHTML = ""; } } InvestingChannelQueue.push(function() { ic_page = InvestingChannel.UAT.Run("5c5a75c3-8896-4592-98f8-dc06e6fdcc56"); }); } gaEvent('adspv', 'InvestingChannel_v2', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_US');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '54202302');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });

Elife Holdings Limited: Financial Ratios (10 years), Financial Data | MarketScreener (2024)